You are using an unsupported browser. Please update your browser to the latest version on or before July 31, 2020.
close
You are viewing the article in preview mode. It is not live at the moment.

Binax.io 10k.txt -

The binx io platform is an FDA-cleared and CLIA-waived molecular point-of-care system designed for the rapid detection of Chlamydia and Gonorrhea, providing laboratory-quality results in approximately 30 minutes. Utilizing PCR technology with electrochemical detection, this desktop system enables "test-and-treat" models in various clinical settings, significantly reducing the time from diagnosis to treatment. For more details on the platform, visit mybinxhealth.com . binx health io CT/NG Assay - U.S. Pharmacist

The binx io platform is an FDA-cleared and CLIA-waived molecular point-of-care system designed for the rapid detection of Chlamydia and Gonorrhea, providing laboratory-quality results in approximately 30 minutes. Utilizing PCR technology with electrochemical detection, this desktop system enables "test-and-treat" models in various clinical settings, significantly reducing the time from diagnosis to treatment. For more details on the platform, visit mybinxhealth.com . binx health io CT/NG Assay - U.S. Pharmacist

scroll to top icon